USFDA completes inspection of Eugia Pharma Specialities' Unit II
Aurobindo Pharma announced that the United States Food and Drug Administration (US FDA) inspected Unit-II, a Formulation manufacturing
facility, of Eugia Pharma Specialities Ltd., a wholly owned subsidiary of the Company, situated at Bhiwadi, Alwar, Rajasthan, from 25 April to 03 May 2024.
The inspection closed with 7 observations. The observations are procedural in nature and will be responded to within the stipulated time.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: May 03 2024 | 7:20 PM IST